NTT Communications and VMware Expand Global Cloud Partnership | Latest News

NTT Group (ECTS) and NTM Communications (NTT Com), VMware, Inc. (NYSE: VMW) announced today that it has expanded its cloud partnership for decades, and NTT Com the Enterprise Cloud (ECL) offered by VMware Cloud Foundation. This new service offers VMware's ultimate cloud computing hybrid cloud computing environment and adds a non-frictionless path to the hybrid cloud by adding VMware Hybrid Cloud Extension. As part of this message, NTT Com will become a VMware Cloud Verified Partner and will prove that VMware Cloud Verified logo is compatible with VMware cloud infrastructure.

Combining ECL with VMware Cloud Foundation with NTT Com global MPLS service, Arcstar Universal One (UNO) and Nexcenter data centers, the new service enables businesses to access the cloud safely and easily, or provide any hybrid cloud infrastructure. destroys data centers and clouds.

Safe and convenient transition from the ground to the cloud

ECL customers, developed by VMware Cloud Foundation, do not transfer local VMware workloads to the ECL without altering existing security policies or settings. VMware Hybrid Cloud Extension, which is available as part of this service, provides a large number of frequent, unplanned, retrying or uninterrupted programs. As a result, the risk of workload and shift to the cloud is considerably reduced.

Reference Link : https://www.vmware.com/company/news/releases/vmw-newsfeed.NTT-Communications-and-VMware-Expand-Global-Cloud-Partnership.2205681.html

First major study comparing robotic to open surgery published in The Lancet - Latest News

The first comprehensive study comparing the outcomes of robotic surgery to those of traditional open surgery in any organ has found that the surgeries are equally effective in treating bladder cancer. The seven-year study, conducted at 15 institutions, including Sylvester Comprehensive Cancer Center, and directed by Dipen J. Parekh, M.D., chair of urology and director of robotic surgery at the University of Miami Miller School of Medicine, is published in the June 23 issue of The Lancet.

The Randomized Open Versus Robotic Cystectomy (RAZOR) trial showed lower blood loss and blood transfusion rates and shorter hospital stays for patients who received minimally invasive surgery, but there were no differences in complication rates and the two-year progression-free survival was nearly the same.

"We have done more than 4 million surgeries with the robotic approach since the device came into existence, and on average we do close to a million robotic surgeries a year globally," said Parekh, who is chief clinical officer of the University of Miami Health System. "There are close to 5,000 robotic systems installed all over the world - each one costs about $2 million - and yet until we did this study there was not a single Phase 3 multicenter randomized trial comparing this expensive new technology to the traditional open approach of doing surgeries."

Reference Link : https://www.eurekalert.org/pub_releases/2018-06/uom-fms062118.php